Harvard Management Company’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $31M | Hold |
|
|||||
|
2022
Q4 | $41.6M | Hold |
|
|||||
|
2022
Q3 | $40.6M | Hold |
|
|||||
|
2022
Q2 | $43.7M | Hold |
|
|||||
|
2022
Q1 | $40M | Hold |
|
|||||
|
2021
Q4 | $58.7M | Hold |
|
|||||
|
2021
Q3 | $82.3M | Hold |
|
|||||
|
2021
Q2 | $90.3M | Hold |
|
|||||
|
2021
Q1 | $139M | Hold |
|
|||||
|
2020
Q4 | $165M | Buy |
|